10x Insights
Loading account…
FHLC

Fidelity MSCI Health Care Index ETF

Index fundEquityTracks the MSCI USA IMI Health Care 25/50 IndexETF
FIDELITY COVINGTON TRUST: FHLCHoldings as of Apr 30, 2026Filed Jun 23, 2026

U.S. stock index ETF · tracks MSCI USA IMI Health Care 25/50 Index

As of its 2026 Q2 report, Fidelity MSCI Health Care Index ETF held 340 positions with $2.85B in net assets. Its ten largest holdings made up 50.6% of the fund. The FHLC share class costs 0.08% a year. Over the 12 months to May 2026, FHLC returned 16.8%, with dividends reinvested. In 2026 Q3 it added 14 new positions and exited 17.

2026 Q2 holdings and allocationChanges are against the previous quarter, 2026 Q2Headline fees and returns use the FHLC share class
Expense ratio · FHLC
0.08%
$8 a year for every $10,000 invested
one share class
$2.85B
The whole fund, all share classes
340 holdings
50.6%in the top 10
Weight held in the ten largest holdings
Top 25 hold 73.4%
Return, 1 year · FHLC
+16.8%
With dividends, to May 2026
3 yr total +24.2% · 5 yr total +25.4%
What this fund is
Objective, as filed

Fidelity MSCI Health Care Index ETF seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index.

Strategy, summarised

The fund tracks the MSCI USA IMI Health Care 25/50 Index, which comprises U.S. health care companies classified by GICS, including equipment and service providers as well as pharmaceutical and biotechnology firms. It uses representative sampling, holding a subset of index securities selected to match the index's overall investment and fundamental characteristics rather than all constituents. Because the fund may not hold all securities in the index, its returns may diverge from the index.

What you own

per cent of the fund
CompanyWeightValue
12.13%
$346.22M
8.94%
$255.28M
6.03%
$172.17M
5.42%
$154.71M
4.38%
$124.92M
3.01%
$85.95M
2.91%
$82.96M
2.62%
$74.83M
2.62%
$74.79M
2.55%
$72.78M
Showing 1–10 of 340 · the top 10 are 50.61% of the fund, the top 25 are 73.42%

Reported price is the fund's own reported value divided by its own reported shares at 2026-04-30 — not a live quote, and not what the fund paid.

The 200 largest of 340 holdings, with the share counts as filed, open with a free account.

What the fund is made of

Percentages are of fund net assets. Rounding, liabilities and short positions can make totals differ from 100%.

99.87%
of net assets
Stocks99.64%
Cash & short-term0.23%
Derivatives-0.00%

The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.

Derivatives are shown at market value, not notional exposure.

By sector

Health Care
97.5%
International
2.4%
Cash
0.1%
Industrials
0.0%
1 other sector
0.0%

How it has done

Total return, dividends reinvested · to May 2026

FHLC share class · total returns with dividends reinvested

1 year
+16.76%
3 years
+24.17%
Cumulative, not per year
5 years
+25.42%
Cumulative, not per year
Largest decline in 3 years
-14.99%
From a previous high to a later low
Cumulative return, last three years· Aug 2023 – May 2026

Volatility over the last 12 months: 14.73%. Past returns are a record, not a forecast.

Jun 2026 and Jul 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

Fees & fund details

Fidelity MSCI Health Care Index ETF is a U.S. equity index ETF that tracks the MSCI USA IMI Health Care 25/50 Index. 20% of FHLC’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 95% of the fund’s equity).

Asset class
Equity
Region
United States
Management
Index (passive)
Fund type
ETF
Features
Non-diversified
Expense ratio, by class
0.08%· FHLC 0.08%
Portfolio turnover
3.00% a year · as of 2025 Q4

Turnover is how much of the portfolio was replaced in a year.

Classified from what the fund holds, not from its name · 2026 Q2. The summary is a paraphrase of the prospectus; the objective is verbatim.

What changed this quarter

2026 Q3 vs 2026 Q2

Positions that entered or left the fund since its previous filing. Positions that were only resized are not listed.

17 exited· the largest 8

Masimo Corp
Nuvalent IncNUVL
Catalyst Pharmaceuticals IncCPRX
Apellis Pharmaceuticals Inc
Terns Pharmaceuticals Inc
Soleno Therapeutics Inc
Select Medical Holdings CorpSEM
Avanos Medical IncAVNS
Connected research

Understand how this fund fits with the rest.

Explore shared holdings, compare funds and follow their businesses with your connected AI:

  • “Where do my funds overlap — FHLC, QQQ and the fund in my 401(k)?”
  • “How do this fund’s ten biggest holdings stack up against each other?”
  • “For my target-date fund, what’s the real stock-and-bond mix once you look through it?”
See how it works →All research tools with a subscription. Use your own AI account.